Public Health Grand Rounds: Prevention and Control of Skin Cancer

Public Health Grand Rounds: Prevention and Control of Skin Cancer

The April session of CDC’s Public Health Grand Rounds will discuss skin cancer prevention. It will be available via live webcast from CDC’s headquarters in Atlanta, Georgia on Tuesday, April 21, at 1 p.m. EDT.

Skin cancer is the most common kind of cancer in the United States, affecting 5 million people each year. The two most common types of skin cancer—basal cell and squamous cell carcinomas—are highly curable, but can be disfiguring and costly. Melanoma, the third most common skin cancer, is more dangerous and causes about 9,000 deaths each year.

Skin cancer is a serious public health concern. Unlike most other cancers, skin cancer rates continue to increase. The most preventable cause of skin cancer is exposure to ultraviolet (UV) light from the sun or from tanning beds. Our panel of experts will talk about how we can help people protect their skin while enjoying the outdoors.

E-mail your questions about this topic before or during the session. Live tweets will be posted on @CDC_Cancer with the hashtag #CDCGrandRounds.

Presentions

“Skin Cancer: Common and Preventable”
Meg Watson, MPH
Epidemiologist, Epidemiology and Applied Research Branch
Division of Cancer Prevention and Control, CDC

“Skin Cancer Prevention in Arizona”
Sharon McKenna, BA
Program Manager, Arizona SunWise Skin Cancer Prevention Program
Bureau of Epidemiology & Disease Control, Arizona Department of Health Services

“Melanoma Moon Shot: MD Anderson’s Comprehensive Approach to Melanoma and Skin Cancer”
Jeff Gershenwald, MD
Medical Director, Melanoma and Skin Center
University of Texas MD Anderson Cancer Center

“A Comprehensive Approach to Skin Cancer Prevention”
Boris Lushniak, MD, MPH
Rear Admiral, U. S. Public Health Service
Deputy Surgeon General

Continuing Education

Continuing education will be available until February 18, 2016. For more information, see Public Health Grand Rounds: Prevention and Control of Skin Cancer. [PDF-284KB]